Skip to main content
NVDA-2.10%AAPL+2.69%GOOGL+0.24%MSFT+0.56%AMZN+0.12%TSM-0.81%SPCX+2.02%AVGO+0.03%META-0.22%TSLA-0.47%SKHY-3.57%MU-4.31%BRK-B-0.24%LLY+0.25%JPM-0.60%WMT+0.20%AMD-2.67%V-0.09%XOM+0.78%ASMLa-1.66%JNJ-0.19%INTC-4.47%MA-0.42%0700.HK-1.94%1398.HK+0.79%ORCL-2.97%ABBV+0.61%BAC-0.65%CSCO-0.91%CVX0.00%COST-0.01%KO+0.78%LRCX-4.62%CAT-1.46%AP2d-1.55%0005.HK-0.78%AMAT-2.16%UNH-0.23%HSBA.L-1.30%DELL-3.64%PG-0.05%MS-0.60%GE-0.47%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.05%HD-1.35%0939.HK+1.66%GS-0.76%NZDJPY-2.49%AUDJPY-1.75%CHFJPY-1.55%NZDCAD-1.40%EURNZD+1.34%GBPNZD+1.32%USDJPY-1.27%NZDUSD-1.25%EURJPY-1.20%GBPJPY-1.18%CADJPY-1.10%NZDCHF-0.97%USDZAR+0.89%USDNOK+0.82%EURZAR+0.79%USDSEK+0.77%AUDNZD+0.77%GBPZAR+0.74%EURNOK+0.72%AUDCAD-0.68%EURSEK+0.67%AUDDKK-0.60%CHFNOK+0.59%EURAUD+0.56%GBPAUD+0.55%USDTHB+0.54%CHFSEK+0.53%AUDUSD-0.49%AUDSGD-0.48%CADCHF+0.43%USDMXN+0.43%GBPTRY+0.41%NOKJPY-0.35%USDPLN+0.35%GBPCHF+0.35%EURCHF+0.34%GBPHKD+0.32%NZDSGD-0.31%USDCHF+0.29%GBPMXN-0.28%SGDJPY+0.25%EURPLN+0.25%USDSGD+0.21%AUDCHF-0.21%USDILS+0.16%USDCAD-0.15%AUDNOK+0.12%NZDMXN-0.12%PLNJPY+0.12%EURSGD+0.11%EURHKD-0.11%USDTRY+0.11%GBPCAD-0.10%USDDKK+0.10%EURCAD-0.10%EURCZK-0.08%USDCNH+0.08%GBPUSD+0.08%EURUSD+0.06%GBPSGD+0.06%USDCOP-0.04%CHFSGD-0.02%USDHKD+0.01%EURGBP+0.01%EURDKK0.00%EURCNH0.00%XPTUSD-5.22%UKOIL+4.94%USOIL+4.58%HG1-4.54%GAGUSD-4.20%XAGUSD-4.20%GAUUSD-0.80%XAUUSD-0.80%COTTON+0.67%S1+0.49%XNGUSD+0.48%COFFEE-0.46%BTCUSD-1.38%ETHUSD-0.57%USDTUSD-0.02%XRPUSD-2.75%SOLUSD-1.67%TRXUSDT+0.03%ZECUSDT-8.60%DOGEUSD-2.91%XMRUSDT-0.86%LINKUSD-1.49%XLMUSD-1.82%BCHUSDT-9.83%LTCUSD-1.56%UNIUSD-2.61%TONUSD+24.88%HBARUSDT-2.10%SUIUSD-3.76%TAOUSDT-4.65%AAVEUSD-2.57%DOTUSDT-2.67%ICPUSDT-1.78%ONDOUSDT-3.23%WLDUSDT-2.67%ATOMUSDT-3.51%ARBUSDT-0.87%JUPUSDT-4.25%INJUSDT-3.68%STXUSDT-4.16%FETUSDT-3.86%TIAUSDT-1.65%PYTHUSDT-1.33%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.02%WIFUSDT-5.38%OPUSDT-3.00%POLUSDT-4.56%IOTAUSDT-3.87%AXSUSDT-2.36%FARTCOINUSDT-4.03%EOSUSDT-2.91%DYDXUSDT-2.49%ORDIUSDT-1.37%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.10%AAPL+2.69%GOOGL+0.24%MSFT+0.56%AMZN+0.12%TSM-0.81%SPCX+2.02%AVGO+0.03%META-0.22%TSLA-0.47%SKHY-3.57%MU-4.31%BRK-B-0.24%LLY+0.25%JPM-0.60%WMT+0.20%AMD-2.67%V-0.09%XOM+0.78%ASMLa-1.66%JNJ-0.19%INTC-4.47%MA-0.42%0700.HK-1.94%1398.HK+0.79%ORCL-2.97%ABBV+0.61%BAC-0.65%CSCO-0.91%CVX0.00%COST-0.01%KO+0.78%LRCX-4.62%CAT-1.46%AP2d-1.55%0005.HK-0.78%AMAT-2.16%UNH-0.23%HSBA.L-1.30%DELL-3.64%PG-0.05%MS-0.60%GE-0.47%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.05%HD-1.35%0939.HK+1.66%GS-0.76%NZDJPY-2.49%AUDJPY-1.75%CHFJPY-1.55%NZDCAD-1.40%EURNZD+1.34%GBPNZD+1.32%USDJPY-1.27%NZDUSD-1.25%EURJPY-1.20%GBPJPY-1.18%CADJPY-1.10%NZDCHF-0.97%USDZAR+0.89%USDNOK+0.82%EURZAR+0.79%USDSEK+0.77%AUDNZD+0.77%GBPZAR+0.74%EURNOK+0.72%AUDCAD-0.68%EURSEK+0.67%AUDDKK-0.60%CHFNOK+0.59%EURAUD+0.56%GBPAUD+0.55%USDTHB+0.54%CHFSEK+0.53%AUDUSD-0.49%AUDSGD-0.48%CADCHF+0.43%USDMXN+0.43%GBPTRY+0.41%NOKJPY-0.35%USDPLN+0.35%GBPCHF+0.35%EURCHF+0.34%GBPHKD+0.32%NZDSGD-0.31%USDCHF+0.29%GBPMXN-0.28%SGDJPY+0.25%EURPLN+0.25%USDSGD+0.21%AUDCHF-0.21%USDILS+0.16%USDCAD-0.15%AUDNOK+0.12%NZDMXN-0.12%PLNJPY+0.12%EURSGD+0.11%EURHKD-0.11%USDTRY+0.11%GBPCAD-0.10%USDDKK+0.10%EURCAD-0.10%EURCZK-0.08%USDCNH+0.08%GBPUSD+0.08%EURUSD+0.06%GBPSGD+0.06%USDCOP-0.04%CHFSGD-0.02%USDHKD+0.01%EURGBP+0.01%EURDKK0.00%EURCNH0.00%XPTUSD-5.22%UKOIL+4.94%USOIL+4.58%HG1-4.54%GAGUSD-4.20%XAGUSD-4.20%GAUUSD-0.80%XAUUSD-0.80%COTTON+0.67%S1+0.49%XNGUSD+0.48%COFFEE-0.46%BTCUSD-1.38%ETHUSD-0.57%USDTUSD-0.02%XRPUSD-2.75%SOLUSD-1.67%TRXUSDT+0.03%ZECUSDT-8.60%DOGEUSD-2.91%XMRUSDT-0.86%LINKUSD-1.49%XLMUSD-1.82%BCHUSDT-9.83%LTCUSD-1.56%UNIUSD-2.61%TONUSD+24.88%HBARUSDT-2.10%SUIUSD-3.76%TAOUSDT-4.65%AAVEUSD-2.57%DOTUSDT-2.67%ICPUSDT-1.78%ONDOUSDT-3.23%WLDUSDT-2.67%ATOMUSDT-3.51%ARBUSDT-0.87%JUPUSDT-4.25%INJUSDT-3.68%STXUSDT-4.16%FETUSDT-3.86%TIAUSDT-1.65%PYTHUSDT-1.33%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.02%WIFUSDT-5.38%OPUSDT-3.00%POLUSDT-4.56%IOTAUSDT-3.87%AXSUSDT-2.36%FARTCOINUSDT-4.03%EOSUSDT-2.91%DYDXUSDT-2.49%ORDIUSDT-1.37%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%
AP

ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ • Healthcare

$5.23
-$0.15 (-3.0%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$5.35
Previous Close$5.23
Day Range$5.22 - $5.38
Avg. Volume (3M)1.6M
Market Cap$508.4M
52 Week Range
$4.91$13.15
Next EarningsIn 60 daysNov 9, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$33.6M100%
Gross Profitminus cost of goods$20.8M62%

Fundamentals & Financials

Revenue (TTM)
$116.9M
Net Income (TTM)
-$215.4M
EPS (TTM)
-$2.18
ROA (TTM)
-86.35%
Current Ratio
3.48

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

0.0%Q1 2026-$0.42
-15.1%Q2 2026-$0.61
-31.9%Q3 2026-$0.63
Next

Nov 9

in 60 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc. develops nasal-spray treatments in biotechnology and trades on the NASDAQ as SPRY. Its business centers on intranasal epinephrine products for severe allergic reactions, and it recorded $84.3 million of revenue in FY2025. The company was founded in 2015 and is based in San Diego, California.

Name
ARS Pharmaceuticals, Inc.
CEO
Donn Casale
Website
ars-pharma.com
Industry
Healthcare
Year Founded
2015
Employees
195

Today's Snapshot

AI-generated

SPRY is trading 2.6% below yesterday's close, while its sector was flat. SPRY remains within 3.8% of its 52-week low of 4.91. ARS Pharmaceuticals faces a class-action lawsuit, with investors’ deadline to lead the case set for October 5.

Trading Volume

Below 10d avg (1.1M)

396K

vs S&P 500 Today

Underperforming Market

-2.02%

Updated: September 10, 2026 at 16:34 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
SPRY, trading near $5.09, shows a bearish technical picture with price well below its short-, medium- and long-term moving averages and both CCI and MACD pointing to sustained downside momentum. ADX in the mid-20s indicates a developing but meaningful downtrend, while elevated volatility—ATR around 6.8%—and a heavily negative on-balance volume profile suggest distribution and episodic moves lower. Oscillators register extreme short-term oversold conditions that may produce intermittent bounces, however they have not altered the dominant pattern. Technical takeaway: Strong Sell — price below key averages, negative volume and selling momentum confirm the bearish bias.
All signals
  • EMA (5 indicators)$5.53 - $8.10
    Sell
  • RSI (14)35.03
    Neutral
  • Stochastic %K (14, 3, 3)5.68
    Buy
  • MACD Level (12, 26)-0.26
    Sell

Peers & Related Assets

PVLAPalvella Therapeutics, Inc.
$151.34-0.6%
TYRATyra Biosciences, Inc.
$22.01-17.7%
SVRASavara Inc.
$5.42-2.0%
KURAKura Oncology, Inc.
$12.09-3.4%
ABUSArbutus Biopharma Corp
$5.17-0.2%
LENZLENZ Therapeutics, Inc.
$4.91-7.9%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.